Bar Harbor Wealth Management decreased its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 10.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 26,170 shares of the conglomerate's stock after selling 3,111 shares during the period. Bar Harbor Wealth Management's holdings in Danaher were worth $5,365,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also bought and sold shares of DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth about $27,000. Hurley Capital LLC acquired a new stake in Danaher during the 4th quarter worth approximately $34,000. Rialto Wealth Management LLC bought a new stake in Danaher during the 4th quarter worth approximately $34,000. Kentucky Trust Co acquired a new position in Danaher in the 4th quarter valued at approximately $34,000. Finally, Rakuten Securities Inc. raised its stake in shares of Danaher by 380.0% during the fourth quarter. Rakuten Securities Inc. now owns 168 shares of the conglomerate's stock valued at $39,000 after acquiring an additional 133 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
DHR has been the subject of several analyst reports. Citigroup restated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Guggenheim reissued a "buy" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. TD Cowen upped their price target on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. lowered their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Finally, Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research report on Monday, June 9th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average price target of $248.17.
Read Our Latest Stock Analysis on Danaher
Insider Transactions at Danaher
In other news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.
Danaher Price Performance
DHR stock traded up $0.47 during mid-day trading on Monday, hitting $201.14. The company had a trading volume of 3,057,529 shares, compared to its average volume of 3,489,071. The company has a 50-day moving average price of $192.80 and a 200 day moving average price of $210.81. Danaher Co. has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a market capitalization of $143.95 billion, a price-to-earnings ratio of 38.09, a P/E/G ratio of 2.66 and a beta of 0.77. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The firm had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. Danaher's dividend payout ratio (DPR) is 24.85%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.